Ep. 367 The Metabolic Health Crisis & GLP-1s with Dr. Anurag Singh

Everyday Wellness with Cynthia Thurlow ™

Cynthia Thurlow

Alternative Health, Nutrition, Science, Life Sciences, Health & Fitness

4.8 • 1K Ratings

🗓️ 5 June 2024

⏱️ 45 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

I am delighted to reconnect with Dr. Anurag Singh today, the Chief Medical Officer at Timeline Nutrition. He joined me once before on Episode 268. I invited Dr. Singh back to discuss the latest research on GLP-1 agonists like Wegovy, Semaglutide, and Ozempic, which are gaining significant traction with projected sales exceeding $100 billion by 2030, potentially affecting 9% of the US population. In our conversation, we explore the contributors to our metabolic health crisis by looking at the research surrounding GLP-1 agonists, the physiology of GLP-1 peptides, and the influencing elements Dr. Singh refers to as the trifecta. We dive into the loss of muscle mass and strength, sarcopenia, and frailty associated with these drugs, and Dr. Singh shares his concerns about their impact on bone health, the gut microbiome, and their use in younger patients. We also get into lifestyle measures, mitochondrial health, hallmarks of aging, Akkermansia, and the importance of advocacy and patient empowerment. Today’s compelling and invaluable discussion with Dr. Anurag Singh highlights crucial insights into GLP-1 agonists and their broader health implications. I know it will provide significant value for our listeners. IN THIS EPISODE YOU WILL LEARN: Dr. Singh breaks down what GLP-1 agonist drugs are and how they work. How our modern-day lifestyles contribute to poor metabolic health The benefits and side-effects of using GLP-1 agonist treatments for improving metabolic health Why strength training is essential for preventing muscle loss and frailty in middle-aged women What are the potential long-term effects of SARMs on muscle mass and health? Why dietary counseling is essential for those taking GLP-1 agonist drugs The benefits of supplements for boosting mitochondrial health Dr. Singh discusses a research study on combining lithium with GLP-1 agonists to improve the muscle quality of those with muscle-wasting conditions. Why akkermansia is essential for GLP production Connect with Cynthia Thurlow Follow on Twitter Instagram LinkedIn Check out Cynthia’s website Submit your questions to support@cynthiathurlow.com Connect with Dr. Anurag Singh Timeline Mitopure Email Dr. Singh: asingh@amazentis.com Previous Episode Mentioned Ep. 268: Understanding the Biology of Aging with Evolved Supplementation and Nutrition, featuring Dr. Anurag Singh

Transcript

Click on a timestamp to play from that location

0:00.0	Welcome to Everyday Wellness Podcast. I'm your host, Nurse Practitioner Cynthia Thurlow.
0:07.0	This podcast is designed to educate, empower, and inspire you to achieve your health and wellness goals.
0:14.0	My goal and intent is to provide you with the best content and conversations from leaders in the
0:19.2	health and wellness industry each week and impact over a million lives.
0:23.4	Today I had the honor with reconnecting with Dr. Enrag Singh.
0:32.6	He is the chief medical officer at Timeline Nutrition.
0:36.3	He last joined me on episode 268.
0:40.7	I asked him to join me to speak specifically to emerging research and
0:45.9	information on GLP1 Agnes. We know now that 12% of adults have taken a
0:52.1	GLP1 agonist.
0:53.5	These are drugs like Wagoe, semi-glutide,
0:57.6	Ozempic, and 6% are currently taking one.
1:01.7	Interestingly enough, Medicaid in 2022 indicated that these
1:06.0	drugs represented 4.6% of gross Medicaid spend and in the third quarter of
1:11.9	2023 they reached 6.7%.
1:15.0	More interestingly enough,
1:16.7	J.P. Morgan research forecasts that these drugs will exceed
1:20.0	a hundred billion dollars by 2030 and that 30 million people in the US may use the
1:26.4	drugs by then representing about 9% of the population.
1:31.0	Today Dr Singh and I spoke at great length about the metabolic health crisis, the physiology of
1:37.9	GLP1 peptides, what is contributing to our metabolic health crisis,
1:44.4	including what he refers to as the trifecta,
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Cynthia Thurlow, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Cynthia Thurlow and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.